A genetic precision medical center was inaugurated at the Fifth People's Hospital of Zhuhai (formerly Pingsha Hospital in Jinwan District), on Aug 30. It will be operated under an agreement with a subsidiary of Livzon Pharmaceutical Group.
The hospital and Livzon Gene Detection Technology will advance the city's precision medicine -- a model that customizes healthcare with medical treatments and products tailored for each patient.
They will attach great importance to early warning and disease prevention. Earlier diagnosis will be based on accurate prediction of the disease process in high-risk groups with family history and other more sporadic high-risk groups.
Meanwhile, the cooperation will bring medical diagnosis to a genetic level. Accurate diagnosis will be the foundation of precision treatment, a personalized strategy about targeting, immune drug selection, and side effect control.
The medical center intends to offer efficient, targeted, and economical treatment for patients, compared with traditional medical solutions.
Livzon Gene Detection Technology is a global frontrunner in precision medicine with established research and development in monoclonal antibody drugs and molecular therapy.
The company provides full-cycle cancer management through hereditary risk assessment, benign and malignant screening of early pulmonary nodules, targeted and immune drug use instruction, and real-time and recurrence monitoring.
Plaque unveiling [Photos courtesy WeChat account: zhsdwrmyy]